《半日總結》恆指升359點 科網及出口股揚 商湯彈逾13%
美股道指顯著上升754點或2.4%,港股早市隨外圍造好。恆指高開307點,其後升幅曾擴大至450點見21,111點,半日升359點或1.74%,報21,020點;國指升129點或1.82%,報7,226點;恆生科技指數升103點或2.29%,報4,610點。大市半日成交總額490.54億元,滬、深港通南下交易半日分別淨流入11.92億及3.48億元人民幣。
市場憧憬內地監管機構完成對滴滴調查,科網股上升,阿里巴巴(09988.HK)升4.3%報105.2元,騰訊(00700.HK)升2.3%報341元,美團(03690.HK)、京東(09618.HK)、百度(09888.HK)及網易(09999.HK)各升3.3%至4.4%,小米(01810.HK)升1.4%報13.1元,快手(01024.HK)升2.2%報81.1元。
攜程(09961.HK)及嗶哩嗶哩(09626.HK)各升5.1%及8.7%,阿里健康(00241.HK)及華虹半導體(01347.HK)各升3.5%及3.4%。商湯(00020.HK)進行股份回購,股價彈升13.8%,
北京發布促汽車消費措施,加快二手車流通及促汽車消費升級,易鑫(02858.HK)升7.3%,汽車代理商中升(00881.HK)升1.9%。電動車股回吐,理想(02015.HK)及小鵬09868.HK)各跌6.8%及2.5%。
消費股上升,餐飲股海底撈(06862.HK)及百勝中國(09987.HK)各升逾5%,頤海(01579.HK)升4%。華潤啤酒(00291.HK)升3.1%。體育用品股特步(01368.HK)及安踏(02020.HK)各升3%。教育股現炒作,新東方在線(01797.HK)、宇華(06169.HK)及中教(00839.HK)各升逾5%。醫藥股信達生物(01801.HK)、藥明生物(02269.HK)及百濟神州(06160.HK)各升4%至4.9%,綠葉製藥(02186.HK)升3.3%。
美股顯著上升,出口股創科(00669.HK)及敏華(01999.HK)各升逾5%。航運股東方海外(00316.HK)及海豐(01308.HK)各升2.6%及2.7%,中遠海能(01138.HK)及太平洋航運(02343.HK)各升3.5%及3.7%。
澳門與珠海探討疫情穩定後盡快恢復人員往來事宜,澳博(00880.HK)、永利澳門(01128.HK)及美高梅中國(02282.HK)各升2.7%至2.9%。
金融股隨外圍造好,匯控(00005.HK)升1.3%報49.45元,中銀香港(02388.HK)及渣打(02888.HK)各升2.5%及2.9%。港交所(00388.HK)升2.7%報360.8元,友邦(01299.HK)升0.8%報84.2元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.